Literature DB >> 31008296

The very long-term risk and predictors of recurrent ischaemic events after a stroke at a young age: The FUTURE study.

Renate M Arntz1, Mayte E van Alebeek1, Nathalie E Synhaeve1,2, Jeske van Pamelen2, Noortje Amm Maaijwee3, Hennie Schoonderwaldt1, Maureen J van der Vlugt4, Ewoud J van Dijk1, Loes Ca Rutten-Jacobs5, Frank-Erik de Leeuw1.   

Abstract

INTRODUCTION: Patients who suffer a stroke at a young age, remain at a substantial risk of developing recurrent vascular events and information on very long-term prognosis and its risk factors is indispensable. Our aim is to investigate this very long-term risk and associated risk factors up to 35 years after stroke. PATIENTS AND METHODS: Prospective cohort study among 656 patients with a first-ever ischaemic stroke or transient ischaemic stroke (TIA), aged 18-50, who visited our hospital (1980-2010). Outcomes assessed at follow-up (2014-2015) included TIA or ischaemic stroke and other arterial events, whichever occurred first. Kaplan-Meier analysis quantified cumulative risks. A prediction model was constructed to assess risk factors independently associated with any ischaemic event using Cox proportional hazard analyses followed by bootstrap validation procedure to avoid overestimation.
RESULTS: Mean follow-up was 12.4 (SD 8.2) years (8105 person-years). Twenty-five years cumulative risk was 45.4% (95%CI: 39.4-51.5) for any ischaemic event, 30.1% (95%CI: 24.8-35.4) for cerebral ischaemia and 27.0% (95%CI: 21.1-33.0) for other arterial events. Risk factors retained in the prediction model were smoking (HR 1.35, 95%CI: 1.04-1.74), poor kidney function (HR 2.10, 95%CI: 1.32-3.35), history of peripheral arterial disease (HR 2.10, 95%CI: 1.08-3.76) and cardiac disease (HR 1.84, 95%CI: 1.06-3.18) (C-statistic 0.59 (95%CI: 0.55-0.64)). DISCUSSION AND
CONCLUSION: Young stroke patients remain at a substantial risk for recurrent events; almost 1 of 2 develops a recurrent ischaemic event and 1 of 3 develops a recurrent stroke or TIA during 25 years of follow-up. Risk factors independently associated with recurrent events were poor kidney function, smoking, history of peripheral arterial disease and cardiac disease.

Entities:  

Keywords:  Young stroke; cardiovascular disease; prognosis; risk factors

Year:  2016        PMID: 31008296      PMCID: PMC6301250          DOI: 10.1177/2396987316673440

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  22 in total

1.  Experience from a multicentre stroke register: a preliminary report.

Authors:  S Hatano
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls.

Authors:  Stuart J Pocock; Tim C Clayton; Douglas G Altman
Journal:  Lancet       Date:  2002-05-11       Impact factor: 79.321

3.  Recurrent ischemic events in young adults after first-ever ischemic stroke.

Authors:  Jukka Putaala; Elena Haapaniemi; Antti J Metso; Tiina M Metso; Ville Artto; Markku Kaste; Turgut Tatlisumak
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

4.  Do all young ischemic stroke patients need long-term secondary preventive medication?

Authors:  H Naess; U Waje-Andreassen; L Thomassen; H Nyland; K M Myhr
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

5.  Universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Fred S Apple; Marcello Galvani; Hugo A Katus; L Kristin Newby; Jan Ravkilde; Bernard Chaitman; Peter M Clemmensen; Mikael Dellborg; Hanoch Hod; Pekka Porela; Richard Underwood; Jeroen J Bax; George A Beller; Robert Bonow; Ernst E Van der Wall; Jean-Pierre Bassand; William Wijns; T Bruce Ferguson; Philippe G Steg; Barry F Uretsky; David O Williams; Paul W Armstrong; Elliott M Antman; Keith A Fox; Christian W Hamm; E Magnus Ohman; Maarten L Simoons; Philip A Poole-Wilson; Enrique P Gurfinkel; José-Luis Lopez-Sendon; Prem Pais; Shanti Mendis; Jun-Ren Zhu; Lars C Wallentin; Francisco Fernández-Avilés; Kim M Fox; Alexander N Parkhomenko; Silvia G Priori; Michal Tendera; Liisa-Maria Voipio-Pulkki; Alec Vahanian; A John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Gerasimos Filippatos; Christian Funck-Brentano; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; José Luis Zamorano; Joao Morais; Sorin Brener; Robert Harrington; David Morrow; Michael Lim; Marco A Martinez-Rios; Steve Steinhubl; Glen N Levine; W Brian Gibler; David Goff; Marco Tubaro; Darek Dudek; Nawwar Al-Attar
Journal:  Circulation       Date:  2007-10-19       Impact factor: 29.690

6.  Ischaemic stroke in young adults: predictors of outcome and recurrence.

Authors:  K Nedeltchev; T A der Maur; D Georgiadis; M Arnold; V Caso; H P Mattle; G Schroth; L Remonda; M Sturzenegger; U Fischer; R W Baumgartner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

7.  Retrospective assessment of initial stroke severity with the NIH Stroke Scale.

Authors:  L S Williams; E Y Yilmaz; A M Lopez-Yunez
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

8.  Long-term prognosis of ischemic stroke in young adults. Study of 272 cases.

Authors:  J F Varona; F Bermejo; J M Guerra; J A Molina
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

9.  Long-term outcome of cerebral infarction in young adults.

Authors:  H Naess; H I Nyland; L Thomassen; J Aarseth; K-M Myhr
Journal:  Acta Neurol Scand       Date:  2004-08       Impact factor: 3.209

10.  Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

Authors:  M G Bousser; P Amarenco; A Chamorro; M Fisher; I Ford; K Fox; M G Hennerici; H P Mattle; P M Rothwell
Journal:  Cerebrovasc Dis       Date:  2009-04-16       Impact factor: 2.762

View more
  1 in total

1.  Association of SLC6A4 methylation with long-term outcomes after stroke: focus on the interaction with suicidal ideation.

Authors:  Hee-Ju Kang; Eun-Hye Lee; Ju-Wan Kim; Sung-Wan Kim; Il-Seon Shin; Joon-Tae Kim; Man-Seok Park; Ki-Hyun Cho; Jung-Soo Han; In Kyoon Lyoo; Jae-Min Kim
Journal:  Sci Rep       Date:  2021-02-01       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.